2157.HK
LEPU BIO-B
HK$4.18
-1.88%
2026-06-01
About LEPU BIO-B
Lepu Biopharma Co., Ltd., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drug candidates in anti-tumor targeted therapy and oncology immunotherapy in China and internationally. The company offers PUYOUHENG (Pucotenlimab Injection), a humanized IgG4 mAb against human PD-1 for the treatment of MSI-H/dMMR solid tumors solid tumors and melanoma. It is also developing MRG003 that is in phase III clinical study for treating nasopharyngeal cancer, and head and neck squamous cell carcinoma; CMG901 CLDN18.2-targeted ADC, which is in phase III trials for treating gastric and gastroesophageal junction carcinoma and other solid tumors; and MRG004A TF-targeted ADC, which is in phase III clinical trial for treating pancreatic ductal adenocarcinoma. In addition, the company is developing CG00705 Oncolytic virus for treating bacillus calmette-guerin unresponsive non-muscle invasive bladder cancer; and MRG002, which is in phase III trials to treat breast cancer, as well as HER2-positive. Further, the company is developing MRG001 CD20-targeted ADC for treating non-Hodgkin's lymphoma; MRG006A, MRG007, and CTM012 for the treatment of solid tumors. Lepu Biopharma Co., Ltd. was incorporated in 2018 and is headquartered in Shanghai, China. Lepu Biopharma Co., Ltd. operates as a subsidiary of Ningbo Houde Yimin Information Technology Co., Ltd.
Key Fundamentals
P/E Ratio
25.06
EPS (TTM)
HK$0.17
ROE
25.3%
Revenue Growth (YoY)
100.0%
Profit Margin
28.0%
Debt/Equity
78.06
Price/Book
4.79
Beta
-0.41
Market Cap
HK$7.69B
Avg Volume (10D)
9.1M
Recent Breakout Signals
No recent breakout signals detected for 2157.HK.
Recent Price Range (60 Days)
60D High
HK$6.65
60D Low
HK$3.90
Avg Volume
13.2M
Latest Close
HK$4.18
Get breakout alerts for 2157.HK
Sign up for Breakout Scanner to receive daily notifications when 2157.HK triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
LEPU BIO-B (2157.HK) is listed on the Hong Kong Exchanges (HKEX). Breakout Scanner monitors 2157.HK daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 2157.HK operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.